Xiaowen He

502 total citations
25 papers, 381 citations indexed

About

Xiaowen He is a scholar working on Immunology, Molecular Biology and Epidemiology. According to data from OpenAlex, Xiaowen He has authored 25 papers receiving a total of 381 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Immunology, 8 papers in Molecular Biology and 7 papers in Epidemiology. Recurrent topics in Xiaowen He's work include Immunotherapy and Immune Responses (9 papers), Hepatitis B Virus Studies (6 papers) and CAR-T cell therapy research (4 papers). Xiaowen He is often cited by papers focused on Immunotherapy and Immune Responses (9 papers), Hepatitis B Virus Studies (6 papers) and CAR-T cell therapy research (4 papers). Xiaowen He collaborates with scholars based in China, United States and Australia. Xiaowen He's co-authors include Shuhan Sun, Ying He, Fang Wang, Lei Jiang, Ka Li, Ding Ren, Yiming Lu, Fei‐Xiang Ding, Kaihui Wang and Dean Li and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Hepatology.

In The Last Decade

Xiaowen He

25 papers receiving 371 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaowen He China 12 185 166 68 51 43 25 381
Annette Boese Germany 13 307 1.7× 83 0.5× 42 0.6× 63 1.2× 21 0.5× 20 500
Yu-Tsueng Liu United States 9 216 1.2× 88 0.5× 72 1.1× 43 0.8× 21 0.5× 9 485
Yoan Machado Canada 13 210 1.1× 119 0.7× 46 0.7× 46 0.9× 29 0.7× 21 459
Anna‐Karin Roos Sweden 7 144 0.8× 222 1.3× 54 0.8× 38 0.7× 31 0.7× 8 386
Ingrid Tubbe Germany 6 163 0.9× 297 1.8× 48 0.7× 37 0.7× 57 1.3× 9 503
Nicolás Oscar Amiano Argentina 14 102 0.6× 175 1.1× 127 1.9× 139 2.7× 47 1.1× 22 482
Burcu Temizoz Japan 12 220 1.2× 431 2.6× 50 0.7× 76 1.5× 103 2.4× 15 530
Jia Shi China 13 153 0.8× 237 1.4× 98 1.4× 27 0.5× 99 2.3× 25 557
Corinne Cayatte United States 14 172 0.9× 196 1.2× 215 3.2× 106 2.1× 57 1.3× 22 575
Lauren M. Popov United States 9 196 1.1× 131 0.8× 81 1.2× 98 1.9× 22 0.5× 9 413

Countries citing papers authored by Xiaowen He

Since Specialization
Citations

This map shows the geographic impact of Xiaowen He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaowen He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaowen He more than expected).

Fields of papers citing papers by Xiaowen He

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaowen He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaowen He. The network helps show where Xiaowen He may publish in the future.

Co-authorship network of co-authors of Xiaowen He

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaowen He. A scholar is included among the top collaborators of Xiaowen He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaowen He. Xiaowen He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Chang, Yao-Jen, Ping He, Xiaowen He, et al.. (2024). Quantitative trait loci mapping and genomic selection for leaf-related traits in a ‘Luli’ × ‘Red No. 1’ apple hybrid population. Scientia Horticulturae. 339. 113863–113863. 1 indexed citations
3.
Ding, Kai, Xiaowen He, Dan Liang, et al.. (2024). Alanyl-Glutamine Inhibits the Epithelial-Mesenchymal Transition of Airway Epithelial Cells in Asthmatic Mice via DPP4-SIRT1 Pathway. International Archives of Allergy and Immunology. 186(4). 1–18. 1 indexed citations
4.
Luo, Xinran, Yuting Zhang, Jingyi Yu, et al.. (2024). Armored Multivalent CAR-T Cells Targeting BCMA, GPRC5D, and CD38 Eradicate Antigen-Heterogeneous Multiple Myeloma, Address Antigen Escape and Enhance Expansion. Blood. 144(Supplement 1). 2038–2038. 2 indexed citations
5.
Luo, Xinran, et al.. (2024). CAR T-cell therapy for systemic lupus erythematosus: current status and future perspectives. Frontiers in Immunology. 15. 1476859–1476859. 16 indexed citations
6.
Pei, Zhipeng, et al.. (2023). MiR-146a-5p delivered by hucMSC extracellular vesicles modulates the inflammatory response to sulfur mustard-induced acute lung injury. Stem Cell Research & Therapy. 14(1). 149–149. 18 indexed citations
8.
Cai, Ying, Zhibo Wang, Sifan Guo, et al.. (2023). Detection, mechanisms, and therapeutic implications of oncometabolites. Trends in Endocrinology and Metabolism. 34(12). 849–861. 19 indexed citations
9.
Chen, Hongquan, Zhao Yang, Xiaoyun Shen, et al.. (2022). The impact of CoronaVac on the neutralization breadth and magnitude of the antibody response to SARS-CoV-2 viruses. Frontiers in Immunology. 13. 990071–990071. 3 indexed citations
10.
Zang, Aiping, Xiaowen He, Ye Zhou, et al.. (2022). Characterization of age-related immune features after autologous NK cell infusion: Protocol for an open-label and randomized controlled trial. Frontiers in Immunology. 13. 940577–940577. 23 indexed citations
11.
Zhou, Lei, Haifeng Liang, Yuxiang Ge, et al.. (2022). Precisely Targeted Nano‐Controller of PD‐L1 Level for Non‐Small Cell Lung Cancer Spinal Metastasis Immunotherapy. Advanced Healthcare Materials. 11(20). e2200938–e2200938. 23 indexed citations
12.
Ding, Fei‐Xiang, Fang Wang, Yiming Lu, et al.. (2009). Multiepitope peptide-loaded virus-like particles as a vaccine against hepatitis B virus–related hepatocellular carcinoma #. Hepatology. 49(5). 1492–1502. 64 indexed citations
13.
Guo, Yingjun, Ding Ren, Xiaowen He, et al.. (2009). A novel mouse model for immunogenic evaluation of human HBV vaccines. Vaccine. 27(41). 5692–5699. 4 indexed citations
14.
Jiang, Lei, Feng Qian, Xiaowen He, et al.. (2007). Novel chitosan derivative nanoparticles enhance the immunogenicity of a DNA vaccine encoding hepatitis B virus core antigen in mice. The Journal of Gene Medicine. 9(4). 253–264. 40 indexed citations
15.
Song, Shuxia, Fang Wang, Xiaowen He, et al.. (2006). Evaluation of antitumor immunity efficacy of epitope-based vaccine with B16 cell line coexpressing HLA-A2/H-2kb and CTL multiepitope in HLA transgenic mice. Vaccine. 25(25). 4853–4860. 11 indexed citations
16.
Ren, Ding, Fang Wang, Xiaowen He, et al.. (2006). Construction of bioactive chimeric MHC class I tetramer by expression and purification of human–murine chimeric MHC heavy chain and β2m as a fusion protein in Escherichia coli. Protein Expression and Purification. 50(2). 171–178. 9 indexed citations
17.
He, Xiaowen, Lei Jiang, Ding Ren, et al.. (2005). Enhanced immunogenicity of microencapsulated multiepitope DNA vaccine encoding T and B cell epitopes of foot-and-mouth disease virus in mice. Vaccine. 24(12). 2017–2026. 22 indexed citations
18.
He, Xiaowen, Lei Jiang, Fang Wang, et al.. (2005). Augmented humoral and cellular immune responses to hepatitis B DNA vaccine adsorbed onto cationic microparticles. Journal of Controlled Release. 107(2). 357–372. 25 indexed citations
19.
Wang, Fang, et al.. (2005). Non-fusion expression in Escherichia coli: Single-step purification of recombinant human annexin A5 for detection of apoptosis. Protein Expression and Purification. 45(1). 80–87. 11 indexed citations
20.
He, Xiaowen, et al.. (2004). Augmented humoral and cellular immune responses of a hepatitis B DNA vaccine encoding HBsAg by protein boosting. Vaccine. 23(14). 1649–1656. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026